San Francisco, CA, April 9th, 2026 – FormBlends, a health technology platform focused on GLP-1 weight loss results and weight management provider directory listings, today announced the completion of a major platform expansion that positions it as the most comprehensive consumer intelligence resource for prescription weight management medications in the United States. The platform now features 7,282 individually profiled provider listings across all 50 states, 100 physician-reviewed clinical research reports, 17 interactive health tools, and a clinical education library covering every major GLP-1 and peptide therapy on the market.

As the $45 billion GLP-1 market accelerates toward $122 billion by 2030, FormBlends is building the definitive consumer resource for evidence-based medication information, provider transparency, and clinical education.

FormBlends: Building the most comprehensive GLP-1 and peptide intelligence platform on the internet

The announcement comes as the global GLP-1 receptor agonist market reaches $45.3 billion in 2025, projected to hit $122.3 billion by 2030.

Goldman Sachs forecasts the anti-obesity drug market at $95 billion by 2030. J.P. Morgan projects the global incretin market at $200 billion by the same year. Morgan Stanley estimates $77 billion.

1 in 8 American Adults

are currently taking a GLP-1 medication, with an additional 14% expressing interest in starting treatment. Monthly prescriptions for GLP-1 receptor agonists have grown from 700,000 to 2.6 million since 2021.

An Information Crisis in the Fastest-Growing Drug Category

The explosive growth of GLP-1 receptor agonist therapies has created an equally explosive information gap. The National Consumers League documented a 1,200% increase in “violative or problematic” GLP-1-related advertising between 2022 and 2024. Separately, the National Association of Boards of Pharmacy found that approximately 95% of websites offering prescription-only medications online operate outside of legal requirements, with 96% not requiring a valid prescription.

Harvard Medical School researchers have flagged social media as a primary vector for GLP-1 misinformation, with platforms like TikTok rampant with false claims about supplements and foods that supposedly replicate the effects of prescription medications. The FDA has issued multiple warnings about fraudulent products with false labeling entering the market.

“Patients are navigating an information environment where marketing is frequently disguised as medical advice,” said a FormBlends spokesperson. “The gap between what consumers need to know and what they can reliably find online is widening every month. We built this platform to close that gap with physician-reviewed, evidence-based clinical content.”

“We are not building a company that happens to have health content. We are building the most trusted clinical resource on the internet for GLP-1 and peptide therapy information, backed by peer-reviewed research and transparent provider data.”

What FormBlends Has Built: A Platform Overview

1. The National Provider Directory. FormBlends now maintains 7,282 individually profiled weight management clinic listings across all 50 states, each featuring verified ratings, treatment offerings, pricing transparency data, patient review analysis, and an editorially written assessment. Unlike aggregator sites that scrape listings without context, every FormBlends profile includes editorial content reviewed by the platform’s medical team, honest advantages and limitations, and transparent cost comparison information. Provider data is sourced from the Yelp Fusion API and verified quarterly.
2. Clinical Research Library. The platform’s research section houses 100 physician-reviewed reports covering GLP-1 receptor agonists, peptide therapies, and weight management science. Each report cites peer-reviewed sources from journals including the New England Journal of Medicine, JAMA, The Lancet, and Nature Medicine. FormBlends’ ambition is to function as the most complete reference library for GLP-1 and peptide clinical data on the internet, organized and explained for patients rather than clinicians.
3. Interactive Health Tools. FormBlends offers 17 free clinical tools including a BMI calculator, drug interaction checker, insurance coverage checker, dosing schedule planner, peptide dosage calculator, and weight loss timeline estimator. These tools are designed to help patients prepare for conversations with their physicians, not replace medical consultation.
4. Educational Article Library. The platform’s clinical education library includes comprehensive guides organized by drug class and therapeutic category. Article hubs cover GLP-1 receptor agonists, peptide therapy, medication comparisons, side effect profiles, dosing protocols, and cost analyses. Every article is medically reviewed and updated quarterly with current clinical data. All clinical claims cite peer-reviewed sources.

The Clinical Evidence: Why GLP-1 Medications Are Reshaping Medicine

The scale of FormBlends’ investment in clinical education reflects the extraordinary scope of what published research shows GLP-1 receptor agonists are capable of. These medications have demonstrated benefits extending well beyond weight management into cardiovascular disease, kidney disease, and metabolic health, representing what many researchers describe as the most significant pharmacological development in endocrinology in decades.

FormBlends’ research library provides detailed breakdowns of each of these trials, including a comprehensive semaglutide vs tirzepatide comparison, all translated from clinical language into patient-accessible explanations. The platform’s goal is to make published clinical data as accessible as possible, so patients can have informed conversations with their physicians about whether these therapies may be appropriate for their individual circumstances.

A $1.4 Trillion Problem

The economic burden of obesity in the United States is staggering. The Milken Institute and the GWU STOP Obesity Alliance estimate the total economic impact at $1.4 trillion annually when accounting for direct medical expenses and lost productivity.

Adults with obesity incur an average of $2,505 more in annual medical costs than normal-weight adults, with costs escalating to 233.6% higher for individuals with Class 3 obesity. US prescription drug spending hit $805.9 billion in 2024, up 10.2% year-over-year, with weight management medications accounting for 46.8% of the total increase.

Total US spending on GLP-1 receptor agonists grew over 500% from $13.7 billion in 2018 to $71.7 billion in 2023, according to a study published in JAMA Network Open.

$71.7 Billion

Total US GLP-1 receptor agonist spending in 2023, up from $13.7 billion in 2018. Weight management medications drove 46.8% of all US prescription drug spending growth in 2024.

Medicare Coverage: A Catalyst for Information Demand

Beginning July 1, 2026, Medicare will cover select GLP-1 receptor agonist medications for weight management at a $50 per month copay through the new “Medicare GLP-1 Bridge” program, marking the first-ever Medicare coverage for obesity medications after a two-decade exclusion. The CMS BALANCE Model, launching January 2027 for Medicare Part D, is projected to further expand access.

Goldman Sachs projects 15 million US adults will be on anti-obesity medications by 2030, representing 13% of the adult population excluding those with diabetes. J.P. Morgan’s estimate is higher: 25 million Americans by the same year.

“Medicare coverage will bring tens of millions of new patients into this category for the first time,” said a FormBlends spokesperson. “These patients will need reliable, physician-reviewed information to make informed decisions. That is exactly what our clinical resources and research library are designed to provide. We want to be the place physicians recommend their patients go to learn.”

The Peptide Frontier: Education Beyond GLP-1

FormBlends’ platform extends beyond GLP-1 receptor agonists into the broader peptide therapy landscape, which reached $140.86 billion globally in 2025 and is projected to grow to $260.25 billion by 2030 at a 10.77% CAGR.

The platform’s peptide education resources, dosage calculators, and reconstitution reference tools serve a growing consumer segment seeking evidence-based information about therapies gaining attention in longevity and regenerative medicine research. The platform’s retatrutide research hub covers next-generation triple-agonist GLP-1 therapies currently in late-stage clinical trials.

The Search for Answers: Consumer Behavior Signals Demand for Better Resources

Consumer search behavior reflects the intensity of demand for reliable GLP-1 information. The term “GLP-1” now averages over 3 million monthly Google searches, having surpassed “Ozempic” in search volume by early 2025 as consumers shift from brand-name awareness to drug-class research.

A longitudinal analysis published in PMC found that prescription volume and search volume for GLP-1 medications are correlated at r = 0.97, one of the highest correlation coefficients ever recorded between prescription drug utilization and online search behavior. This suggests that patients are actively researching these medications before and during treatment.

This behavioral shift signals a more sophisticated patient population, one that is no longer searching for a brand name from a television commercial but actively comparing clinical evidence, evaluating providers, and assessing costs before making treatment decisions. FormBlends’ provider comparison tools, head-to-head treatment analyses, and ranked provider guides are built specifically for this informed patient.

A New Face of Wellness

FormBlends’ thesis is that the GLP-1 era represents a fundamental shift in how Americans relate to their own health. For the first time, millions of people who were told that weight management was purely a matter of willpower have access to medications that address underlying biological mechanisms, medications backed by the largest, most rigorous clinical trial programs in modern endocrinology.

The company’s content philosophy reflects this shift. FormBlends does not position itself as a marketing platform. It provides clinical information, transparent provider data, and educational resources that allow patients to make decisions grounded in evidence rather than advertising. Every page on the platform, from the side effects guides to the provider directory to the health assessment, is reviewed by licensed clinicians and updated with current published data.

“For decades, the wellness industry sold aspiration. We are building something different: a platform that provides clarity. Patients deserve to know what these medications do, what the published clinical evidence shows, and where to find a qualified provider. If we do that well, the rest takes care of itself.”

“The consumer searching for GLP-1 information in 2026 is fundamentally different from the consumer who first typed ‘Ozempic’ into Google in 2023,” said a FormBlends spokesperson. “They are researching drug classes, reading published trial data, and comparing provider credentials before scheduling consultations. We built this entire platform for that patient.”

By the Numbers: FormBlends Platform as of April 2026

Availability

The FormBlends platform is available now at formblends.com. All educational content, research reports, interactive tools, and provider directory listings are free to access. Patients interested in exploring whether physician-supervised treatment may be appropriate for their circumstances can begin with a free health assessment.

About FormBlends

FormBlends is a health technology platform focused on GLP-1 receptor agonist education, peptide therapy research, and clinical health information. The platform combines the largest independently maintained weight management provider directory in the United States with interactive health tools, a peer-reviewed clinical research library, and physician-supervised telehealth consultations. All medical content is reviewed by licensed clinicians. Learn more at formblends.com.

Important Disclosures: This press release is for informational purposes only and does not constitute medical advice. GLP-1 receptor agonist medications are prescription treatments that require evaluation by a licensed healthcare provider. Clinical trial results cited in this release refer to published, peer-reviewed studies of FDA-approved branded medications and may not be representative of outcomes with any other products. Individual results vary. Always consult a qualified healthcare professional before starting any prescription treatment. The FormBlends provider directory is an informational resource; inclusion does not constitute endorsement. Provider data is sourced from publicly available information and verified quarterly.

Media Contact

FormBlends Communications

Team@formblends.com

formblends.com/about

Chicago, IL, 9th April 2026, ZEX PR WIRE — Educational Awakening Center (EAC Seminars), a platform dedicated to self-awareness, mindset, and personal transformation, continues to expand its educational footprint through a combination of structured seminars and an evolving digital content strategy. Led by CEO Ariya Malek, the organization is focused on helping individuals better understand the underlying patterns that influence their thinking, behavior, and decision-making.

At a time when the personal development industry is saturated with motivational messaging, Educational Awakening Center has taken a different approach. Its programs emphasize clarity and depth rather than surface-level inspiration. The goal is to guide individuals toward identifying the root causes of challenges, allowing them to make more informed and intentional decisions in both their personal and professional lives.

Ariya Malek’s leadership has played a central role in shaping this direction. Through his work, he has consistently emphasized the importance of self-awareness as a foundational skill. Rather than offering quick fixes, his framework encourages individuals to examine how their internal patterns shape external outcomes. This perspective has resonated with a growing audience seeking more structured and practical approaches to personal growth. “Many people are looking for more than motivation,” said Malek. “They want to understand why they think and act the way they do. When individuals gain that clarity, they are better equipped to navigate challenges and create meaningful change.”

Educational Awakening Center delivers this philosophy through a range of learning formats. Its seminars are designed to provide structured, immersive experiences that allow participants to explore key concepts in depth. These sessions focus on helping individuals recognize recurring behavioral patterns and develop a clearer understanding of their decision-making processes.

In parallel, EAC has built a strong presence across digital platforms, where it shares insights in accessible formats. The organization actively publishes content on Substack and X, adapting long-form thought leadership into concise, digestible posts for a broader audience. This approach allows EAC to maintain consistency in its messaging while meeting audiences where they are.

A significant portion of this content is derived from Malek’s contributions to Forbes Councils, where he writes about self-awareness, human behavior, and intentional growth. By repurposing these articles, Educational Awakening Center is able to extend the reach of its ideas while ensuring that its content remains grounded in well-developed frameworks.

The organization also maintains an active presence on platforms such as Facebook and Instagram, where it shares educational insights and engages with its community. This multi-channel strategy reflects a broader understanding of how modern audiences consume information. By presenting ideas in both long-form and short-form formats, EAC is able to connect with individuals at different stages of their personal development journey.

As interest in personal growth continues to rise, Educational Awakening Center is positioning itself as a resource for individuals seeking depth and clarity. The organization’s focus on structured learning experiences sets it apart from more generalized approaches, offering participants tools they can apply beyond the seminar environment.

Looking ahead, EAC plans to continue expanding its educational offerings while refining its digital content strategy. The goal is to create a cohesive ecosystem where individuals can access insights, participate in structured learning, and apply new perspectives in their daily lives. “Our focus is on helping individuals think more clearly about themselves and their decisions,” Malek added. “When people understand the patterns shaping their lives, they gain the ability to change them.”

With a growing audience and a clear emphasis on practical understanding, Educational Awakening Center is steadily building a platform that aligns with the evolving expectations of the personal development space. By combining structured education with accessible digital content, EAC continues to support individuals in developing greater self-awareness and making more intentional choices.

About Educational Awakening Center (EAC Seminars)
Educational Awakening Center is a platform focused on self-awareness, mindset, and personal transformation. Through seminars, written content, and digital platforms, EAC provides structured learning experiences designed to help individuals better understand the patterns that influence their thinking and behavior. Led by CEO Ariya Malek, the organization is committed to delivering clear, practical insights that empower individuals to make more informed and intentional decisions. To learn more, visit: https://www.linkedin.com/in/ariyamalek7  

Chicago, IL, 9th April 2026, ZEX PR WIRE — As brands compete for relevance in a fragmented marketplace, marketing strategist John Gordon Nutley is highlighting a major missed opportunity. Older consumers remain one of the most overlooked segments in modern advertising. Nutley argues that outdated assumptions about aging are costing companies both revenue and relevance.

Raised in Tennessee and now based in Jersey City, Nutley has built a reputation for helping organizations rethink their positioning. His work focuses on clarity, purpose, and long-term value. Today, he is urging brands to confront a persistent issue within the industry. Ageism still shapes many marketing strategies. “Too many campaigns portray older adults as fragile or disconnected,” Nutley said. “That image is inaccurate. It is also bad for business. The reality is far more dynamic. Brands that ignore this are missing real opportunities.”

Recent data supports his view. Older consumers control a large share of disposable income. Many are active online and use social media regularly. At the same time, this group is not uniform. Nutley explains that strict age-based segmentation no longer works. People in their 60s and 70s often feel younger than their age. They connect more with lifestyle and values than with labels.

This shift creates both challenges and opportunities. A large portion of older adults are comfortable with technology. However, many still face barriers. Nutley points to the digital divide as a key issue. Some individuals struggle with complex interfaces or unclear designs. He believes the solution is simple. Brands should focus on accessibility. Clear fonts, intuitive navigation, and strong contrast can improve user experience. These changes help older users, but they also benefit everyone. “Accessibility is a strength,” Nutley said. “It improves performance across all audiences. It is not something brands should treat as a limitation.”

Nutley also highlights the importance of language. Many older consumers dislike terms such as “senior” or “elderly.” They prefer language that reflects how they live, not just their age. This requires brands to rethink how they describe their audiences.

He also points to the positivity effect. Research shows that older adults respond better to positive messages. They prefer content that focuses on benefits, meaning, and emotional rewards. Negative or fear-based messaging is less effective. “People want to feel understood,” Nutley said. “They want to see value and purpose. Messaging should reflect that.”

One segment stands out in particular. The group often called “Active Agers” is changing perceptions. These consumers are highly engaged and financially strong. Many own smartphones and manage their lives online. They challenge the stereotype of older individuals as passive or disconnected.

Despite this, many companies struggle to adjust. Internal resistance is a major barrier. Some teams still focus heavily on younger audiences. They believe this builds future loyalty. Nutley sees this as short-term thinking. “In Tennessee, I learned that trust takes time,” he said. “You build loyalty through consistency. You do not wait for the future. You earn it every day.” From his base in New Jersey, Nutley helps companies rethink these assumptions. He uses data, research, and human insight to guide decisions. His approach is practical and grounded. It focuses on real behavior, not outdated beliefs.

He also emphasizes cultural differences. Attitudes toward aging vary across regions. Social norms and economic conditions shape how people view later life. Brands must adapt their strategies to fit each market. “A global strategy needs local understanding,” Nutley said. “You cannot assume one message will work everywhere.”

Nutley’s work reflects a broader philosophy. He believes authenticity creates long-term value. He avoids shallow tactics and quick wins. Instead, he focuses on strategies that align with real human experiences.

As the industry evolves, Nutley sees a clear path forward. Brands must move beyond stereotypes. They must recognize the diversity within older audiences. Most importantly, they must act with intention. “The opportunity is clear,” Nutley said. “Brands just need to see it and respond with honesty.” To learn more about John Gordon Nutley, visit: https://johngordonnj.com/